What is the 13F Pro Quality Score for BTSG?

13F Pro ranks BrightSpring Health Services, Inc. (BTSG) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View BTSG's current score at https://13fpro.ai/research/BTSG (free sign-up required for the full ranking).

Which hedge funds own the most BTSG stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of BTSG include Kohlberg Kravis Roberts & Co. L.P., FMR, BlackRock,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/BTSG as soon as new 13F filings post.

Where does 13F Pro source BTSG data?

All BrightSpring Health Services, Inc. fundamentals and ownership data come directly from SEC EDGAR. BrightSpring Health Services, Inc. files with the SEC under CIK 1865782. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is BTSG in?

BrightSpring Health Services, Inc. (BTSG) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is BTSG research updated on 13F Pro?

BTSG's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

BrightSpring Health Services, Inc.(BTSG)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1865782 BTSG stock profile & AI dashboard →

13F Pro Quality Score

64.3/100

Rank #642 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

91.7/100

Profitability

44.0/100

Balance Sheet

64.9/100

Earnings Quality

30.0/100

Free Cash Flow

41.6/100

Institutional Flow

54.0/100

Revenue Scale

89.0/100

Dilution Risk

73.3/100

BTSG Stock Analysis & AI Quality Score

AI stock analysis and institutional research for BrightSpring Health Services, Inc. (BTSG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BTSG at 64.3/100 on a 32-signal composite quality model, placing it at rank #642 of 2,879 stocks — the top 25% of the AI-ranked universe. BTSG scores in the top quartile across revenue growth (91.7), revenue scale (89.0). Areas of concern include earnings quality (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), BrightSpring Health Services, Inc. reports quarterly revenue of $3.6B, net income of $148.8M, an operating margin of 3.4%. Top institutional holders of BTSG by reported 13-F value include Kohlberg Kravis Roberts & Co. L.P., FMR, BlackRock,, based on the most recent SEC filings. BTSG trades on the Nasdaq exchange and files with the SEC under CIK 1865782. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BTSG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BrightSpring Health Services, Inc. directly from SEC EDGAR. BrightSpring Health Services, Inc.'s 13F Pro composite quality score has ranged between 49 and 64 since 2025, currently 64.3 — an improving long-term trajectory across 12 quarterly and live scoring snapshots.

Revenue

Q1 2026

$3.6B

Net Income

Q1 2026

$148.8M

Free Cash Flow

Q1 2026

$101.4M

Operating Margin

Q1 2026

3.4%

ROIC

Q1 2026

2.7%

D/E Ratio

Q1 2026

1.29

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

$12.91BFY 2025

FY21 —FY25 $12.91B

Net Income

$190.7MFY 2025

FY21 —FY25 $190.7M

Operating Income

$295.3MFY 2025

FY21 —FY25 $295.3M

EPS (Diluted)

$0.87FY 2025

FY21 —FY25 $0.87

Total Assets

$6.41BFY 2025

FY21 —FY25 $6.41B

Total Debt

$2.56BFY 2025

FY21 —FY25 $2.56B

Op. Cash Flow

$490.2MFY 2025

FY21 —FY25 $490.2M

Metric	FY 2025	FY 2021
Revenue	$12.91B	—
Net Income	$190.7M	—
Operating Income	$295.3M	—
EPS (Diluted)	$0.87	—
Total Assets	$6.41B	—
Total Debt	$2.56B	—
Operating Cash Flow	$490.2M	—

AI Insight: BTSG Financial Trends

Revenue surged 82% from $2,730M in Q2 2024 to $3,614M in Q1 2026 while operating cash flow turned strongly positive.

• Revenue grew from $2,730M in Q2 2024 to $3,614M in Q1 2026, a 32% increase.

• Operating cash flow improved from -$15M in Q2 2024 to $123M in Q1 2026.

• Net income increased from $20M in Q2 2024 to $149M in Q1 2026.

• Total debt decreased from $2,661M to $2,551M while equity grew from $1,600M to $1,979M.

⚠ Q4 2024 revenue dropped to $1,859M from $2,907M in Q3 2024, creating volatility pattern.

⚠ Operating cash flow declined from $232M in Q4 2025 to $123M in Q1 2026.

AI Insight: BTSG Ratio Trends

BrightSpring demonstrated sustained profitability improvement with operating margin expanding from 0.6% in Q2 2024 to 3.4% in Q1 2026.

• Operating margin steadily expanded from 0.6% in Q2 2024 to 3.4% in Q1 2026, showing consistent operational improvement.

• ROIC recovered from 1.4% in Q2 2024 to 10.7% in Q1 2026, indicating improving capital efficiency.

• Debt-to-equity ratio declined from 1.68 in Q3 2024 to 1.29 in Q1 2026, reflecting deleveraging progress.

• ROE surged to 30.1% in Q1 2026, up from negative territory in Q3 2024.

⚠ Q4 2024 operating margin of 8.3% was an outlier compared to surrounding quarters, suggesting potential one-time benefits.

Get alerted when BTSG's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for BrightSpring Health Services, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of BTSG

Kohlberg Kravis Roberts & Co. L.P.
$1.8B41,824,259 sh
FMR LLC
$893.9M20,978,533 sh
BlackRock, Inc.
$835.2M19,602,159 sh
Invesco Ltd.
$489.3M11,482,156 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$342.3M8,032,770 sh
VANGUARD CAPITAL MANAGEMENT LLC
$268.3M6,295,746 sh
STATE STREET CORP
$210.2M4,933,941 sh
MANUFACTURERS LIFE INSURANCE COMPANY, THE
$181.5M4,259,265 sh
VOYA INVESTMENT MANAGEMENT LLC
$164.0M1,154,745 sh
GEODE CAPITAL MANAGEMENT, LLC
$151.9M3,564,953 sh

Fund	Value	Shares
Kohlberg Kravis Roberts & Co. L.P.	$1.8B	41,824,259
FMR LLC	$893.9M	20,978,533
BlackRock, Inc.	$835.2M	19,602,159
Invesco Ltd.	$489.3M	11,482,156
VANGUARD PORTFOLIO MANAGEMENT LLC	$342.3M	8,032,770
VANGUARD CAPITAL MANAGEMENT LLC	$268.3M	6,295,746
STATE STREET CORP	$210.2M	4,933,941
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$181.5M	4,259,265
VOYA INVESTMENT MANAGEMENT LLC	$164.0M	1,154,745
GEODE CAPITAL MANAGEMENT, LLC	$151.9M	3,564,953

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put BTSG on your watchlist

Track score changes the day BrightSpring Health Services, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is BTSG a good stock to buy?

13F Pro's AI-powered analysis of BrightSpring Health Services, Inc. (BTSG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BTSG are available on the BTSG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own BTSG?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BTSG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of BrightSpring Health Services, Inc.'s investment landscape.